Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Bachmann

Showing results (151-160 of 250) with videos related to

Pageof 25
Sort By:
European Journal of Immunology|April 26, 2012
Universal vaccine against influenza virus: linking TLR signaling to anti-viral protectionNicole Schmitz, Roger R Beerli, Monika Bauer, et al.
The Journal of Allergy and Clinical Immunology|February 3, 2018
An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIbLisha Zha, Fabiana M S Leoratti, Lichun He, et al.
Vaccines|November 27, 2021
A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion DomainXinyue Chang, Andris Zeltins, Mona O Mohsen, et al.
European Journal of Immunology|February 23, 2005
Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particlesKatrin Schwarz, Edwin Meijerink, Daniel E Speiser, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccinationMona O Mohsen, Ariane C Gomes, Gustavo Cabral-Miranda, et al.
Allergy|August 27, 2024
On the role of antibody affinity and avidity in the IgE-mediated allergic responseMartin F Bachmann, Pascal S Krenger, Mona O Mohsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particlesSusanne A Keller, Caroline E von Allmen, Heather J Hinton, et al.
Thrombosis and Haemostasis|September 6, 2003
Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2Christine Piossek, Karl-Heinz Thierauch, Jens Schneider-Mergener, et al.
European Journal of Immunology|June 23, 2005
A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicityPatrik Maurer, Gary T Jennings, Jörg Willers, et al.
Frontiers in Immunology|February 27, 2023
Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formationXinyue Chang, Xuelan Liu, Byron Martina, et al.
Pageof 25

Showing results (151-160 of 250) with videos related to

Sort By:
Pageof 25
European Journal of Immunology|April 26, 2012
Universal vaccine against influenza virus: linking TLR signaling to anti-viral protectionNicole Schmitz, Roger R Beerli, Monika Bauer, et al.
The Journal of Allergy and Clinical Immunology|February 3, 2018
An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIbLisha Zha, Fabiana M S Leoratti, Lichun He, et al.
Vaccines|November 27, 2021
A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion DomainXinyue Chang, Andris Zeltins, Mona O Mohsen, et al.
European Journal of Immunology|February 23, 2005
Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particlesKatrin Schwarz, Edwin Meijerink, Daniel E Speiser, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccinationMona O Mohsen, Ariane C Gomes, Gustavo Cabral-Miranda, et al.
Allergy|August 27, 2024
On the role of antibody affinity and avidity in the IgE-mediated allergic responseMartin F Bachmann, Pascal S Krenger, Mona O Mohsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particlesSusanne A Keller, Caroline E von Allmen, Heather J Hinton, et al.
Thrombosis and Haemostasis|September 6, 2003
Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2Christine Piossek, Karl-Heinz Thierauch, Jens Schneider-Mergener, et al.
European Journal of Immunology|June 23, 2005
A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicityPatrik Maurer, Gary T Jennings, Jörg Willers, et al.
Frontiers in Immunology|February 27, 2023
Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formationXinyue Chang, Xuelan Liu, Byron Martina, et al.
Pageof 25